![Barbara Krebs-Pohl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Krebs-Pohl
Directeur/Membre du Conseil chez
CASI PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2026
Profil
Dr. Barbara Krebs-Pohl is an Independent Director at Inventiva SA and an Independent Director at CASI Pharmaceuticals, Inc. She is on the Board of Directors at Inventiva SA, CASI Pharmaceuticals, Inc. and Human Immunology Biosciences, Inc. Dr. Krebs-Pohl was previously employed as a Chief Business Officer by MorphoSys AG.
She also served on the board at HIBio, Inc. She received her graduate degree from Universität zu Köln and a doctorate degree from The Johannes Gutenberg University of Mainz.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 0 ( -.--% ) | - $ | 31/03/2026 |
Postes actifs de Barbara Krebs-Pohl
| Sociétés | Poste | Début |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/09/2025 |
| INVENTIVA | Directeur/Membre du Conseil | 30/06/2026 |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Barbara Krebs-Pohl
| Sociétés | Poste | Fin |
|---|---|---|
HIBio, Inc.
 HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Directeur/Membre du Conseil | - |
| MORPHOSYS AG | Corporate Officer/Principal | - |
Formation de Barbara Krebs-Pohl
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
HIBio, Inc.
HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
